Catalyst Wire Dossier Catalyst Wire Dossier

Revanesse Ultra+

· Prollenium Medical Technologies Inc.
Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for Revanesse Ultra+, covering 2017-12-13 to 2019-04-11. Get the full timeline:

Most recent: Clinical Trial Update: Study to Evaluate Safety and Efficacy of Revanesse® Ultra + vs Revanesse® Ultra for Correction of NLF [NA]

See pricing